| Steven Cohen's SAC Capital Raises Inspire Pharmaceuticals Stake Market Folly submits:Steven Cohen's hedge fund firm SAC Capital recently filed a 13G with the SEC regarding shares of Inspire Pharmaceuticals (ISPH). According to the filing, SAC Capital now shows a 4.9% ownership stake in Inspire Pharma with 4,033,829 shares. This is a massive increase in its position as back on December 31st, 2009, it owned 3,932 shares of ISPH. Keep in mind, though, that SAC Capital is a trading oriented firm and as such moves in and out of positions much more swiftly than the hedgies we normally track here at Market Folly. We've covered other recent activity out of Cohen's hedge fund such as its updated stake in The Talbots (TLB) as well as its newly disclosed position in InterMune (ITMN) and lastly its stake in Psychiatric Solutions (PSYS).Complete Story » seekingalpha.com |
Why Titan Pharma's on My Radar This Week VFC submits: Titan Pharmaceuticals (TTNP.OB) is a company and a 'Stock to Watch' this week after shares closed over ten percent to the upside on Monday, most likely in anticipation of a decision by the United States Patent and Trademark Office that is expected to be rendered on Tuesday, June 15th regarding Titan's Probuphine patent.Any extended patent life for Probuphine would significantly boost the value and future potential of Titan Pharmaceuticals, a company already reaping the 8-10% royalty rewards from the Fanapt licensing agreement. Titan has also been awarded a grant from the National Institutes of Health to cover up to $8 million of the cost of the Probuphine confirmatory Phase III trial.Complete Story » seekingalpha.com |
PPD and Lovelace Biomedical and Environmental Research Institute Enter into Collaboration for Laboratory, Preclinical and Clinical Research Services (Business Wire) WILMINGTON, N.C.----PPD, Inc. and Lovelace Biomedical and Environmental Research Institute today announced they have entered into a collaboration focused on future service opportunities for biopharmaceutical and government clients across a range of therapeutic areas. us.rd.yahoo.com |
Alyson Stoner Tips for Crest & Oral-B - Video First and only complete line of oral care products for kids eight and up help encourage healthy oral care habits feedproxy.google.com |
Lymphoma Drug Shows Success Seattle Genetics Inc. said its novel blood cancer treatment, which attacks cancerous cells but ignores healthy ones, shrank tumors in three-quarters of patients with Hodgkin lymphoma, according to a study released Monday. online.wsj.com |